A recent retrospective study has provided evidence that COVID-19 infection may be notably less common in those using supplemental melatonin. It is suggested that this phenomenon may reflect the fact that, via induction of silent information regulator 1 (Sirt1), melatonin can upregulate K63 polyubiquitination of the mitochondrial antiviral-signalling protein, thereby boosting virally mediated induction of type 1 interferons.
link
Tag: medical science
Steve Kirsch, founder of the Covid-19 early treatment fund, has been censored and threatened for advocating successful early coronavirus treatments. Hear his analysis of these options over the jab, mask-wearing and VAERS data
Covid will never be eradicated
Natural immunity is 20X more effective than the vaccines
“We’re not only setting ourselves up for escape mutant viruses, but it’s also really bad public policy”: Dr Robert Malone
In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity
This article reports the novel binding of nigellidine and subsequent blockage of angiotensin-binding proteins. The ACEs-blocking could restore Angiotensin-level, restrict vaso-turbulence in Covid patients and receptor-blocking might stop inflammatory/vascular impairment. Nigellidine may slowdown the vaso-fluctuations due to Angiotensin-deregulations in Covid patients. Angiotensin II-ACE2 binding (ACE-value -294.81) is more favorable than nigellidine-ACE2. Conversely, nigellidine-ACE1 binding-energy/Ki is lower than nigellidine-ACE2 values indicating a balanced-state between constriction-dilatation. Moreover, nigellidine binds to the viral-spike, closer-proximity to its ACE2 binding-domain. Taken together, Covid patients/elderly-patients, comorbid-patients (with hypertensive/diabetic/cardiac/renal-impairment, counting >80% of non-survivors) could be greatly benefited.
link
This video contains an excellent summary of Geert Vanden Bossche’s principal arguments against MASS use of covid vaccines; that would be MASS use
If you understand the basics of Vanden Bossche’s arguments, you can fast-forward through Bigtree’s explanations and get right to the nub. Good review if you are aware of the issues. And a must watch if you are not. ABN
I have voicemail into a doctor who measured troponin levels after vax. 100% of his patients were elevated. This would be subclinical myocarditis in everyone. Also, my neurologist who had 2,000 VAERS reports this year had 0 in her 11 year career up till now.

I heard the levels were very high… like "heart attack" levels. Hope to hear back soon to confirm this. But I think the wheels are about to come off the bus. The FDA has been saying that VAERS is just over-reporting, but my one neurologist example shoots that theory down.
Originally tweeted by Steve Kirsch (@stkirsch) on September 3, 2021.
Majority of population likely has pre-existing immunity to SARS-CoV-2, claim researchers
A team of researchers has conducted a study suggesting that the majority of the global population is likely to have pre-existing T-cell immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.
The team – from the United States and India – says many people who have not yet been exposed to the virus probably already have SARS-CoV-2-reactive T cells as a result of previous exposure to viruses such as influenza and cytomegalovirus (CMV).
The researchers say the study demonstrates that strong immunity among unexposed individuals can arise through cross-reactive T cell receptors (TCRs) against common CMV and influenza antigens that mount an early CD8 T-cell response to clear SARS-CoV-2.
link
Dr Peter McCullough: “American officials have not come clean on vaccine safety… If we had focused on actually treating people, we would have saved hundreds of thousands of lives.”
At 6:40 McCullough provides guidelines for home treatment. His discussion of vaccine safety and govt “malfeasance” starts around 12:00. This is a very good interview with important information on what we don’t know about vaccine safety due to govt non-transparency. ABN
Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview
Conclusions The IFR of COVID-19 in community-dwelling elderly people is lower than previously reported. Very low IFRs were confirmed in the youngest populations.
link
CDC calls people ‘unvaxed’ until 14 days after 2nd vax. This means hospitalizations from ALL 1st vax adverse events & day 1-14 post 2nd vax into ‘unvaxed’ category. This equals 4,186,000 vax injury hospitalizations being called unvaxed over past 9 months.
That’s a lot of beds!
The 4 M # above is a rough estimate, but close. Here’s my math. Post vax Hospitalizations =55,821. VAERS has 1% reporting rate =5,582,100. 1/2 of hospitalizations after 1st vax (I know it’s less), but more than 50% of injuries <14 days 2nd vax = about 0.75x 5,582,100= 4,186,000
Continue reading “CDC calls people ‘unvaxed’ until 14 days after 2nd vax. This means hospitalizations from ALL 1st vax adverse events & day 1-14 post 2nd vax into ‘unvaxed’ category. This equals 4,186,000 vax injury hospitalizations being called unvaxed over past 9 months.”Pfizer developing covid pill “that could be prescribed at the first sign of infection, without requiring hospitalization”
“Success against #COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Wednesday. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”
link
ISRAEL: Massive 3rd Pfizer shot push. Biggest daily increase of new cases on record.
Coincidence or causation?
Would love to know.
Nothing like that is visible in the UK or Iceland.
Is this the first large scale ADE signal?
Originally tweeted by Covid19Crusher (@Covid19Crusher) on September 2, 2021.





